Genetic variations in the IGF-IGFR-IGFBP axis confer susceptibility to lung and esophageal cancer

Genetics and Molecular Research

Volumn 13, Issue 1, 2014, Pages 2107-2119

  Huang, X P ^a   Zhou, W H ^a   Zhang, Y F ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal cancer; Insulin like growth factor; Lung cancer; Meta analysis; Polymorphism

Indexed keywords

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; DNA POLYMORPHISM; ESOPHAGUS CANCER; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IGF 1 GENE; IGF 1R GENE; IGF 2 GENE; IGF 2R GENE; IGFBP1 GENE; IGFBP3 GENE; IGFBP5 GENE; LUNG CANCER; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TUMOR GENE;

CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; LUNG NEOPLASMS; ODDS RATIO; PUBLICATION BIAS; RECEPTORS, SOMATOMEDIN; RISK; SOMATOMEDINS;

EID: 84897933819     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.January.24.17     Document Type: Article

References (31)

1. Braithwaite D, Boffetta P, Rebbeck TR and Meyskens F (2012). Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest Group. Cancer Epidemiol. Biomarkers Prev. 21: 1606-1610.
2. Chen X, Guan J, Song Y, Chen P, et al. (2008). IGF-I (CA) repeat polymorphisms and risk of cancer: a meta-analysis. J. Hum. Genet. 53: 227-238.
3. da Costa BR, Cevallos M, Altman DG, Rutjes AW, et al. (2011). Uses and misuses of the STROBE statement: bibliographic study. BMJ Open 1: e000048.
4. Dong CQ, Liu C, Ma SJ and Gu HY (2011). Association of insulin-like growth factor-1 polymorphism and risk of esophageal cancer. J. Jiangsu Univ. (Medicine Edition) 21: 535-537.
5. Furstenberger G and Senn HJ (2002). Insulin-like growth factors and cancer. Lancet Oncol. 3: 298-302.
6. Han SG, Park KH, Sung JS, Whang YM, et al. (2008). Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population. Lung Cancer 62: 152-161.
7. Hoyo C, Schildkraut JM, Murphy SK, Chow WH, et al. (2009). IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas. Int. J. Cancer 125: 2673-2678.
8. Jackson D, White IR and Riley RD (2012). Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat. Med. 31: 3805-3820.
9. Jemal A, Bray F, Center MM, Ferlay J, et al. (2011). Global cancer statistics. CA Cancer J. Clin. 61: 69-90.
10. Jia YB, Zhang JZ and Yan Y (2008). Association study between a polymorphism in the IGF-I gene and esophageal squamous cell carcinoma. J. Baotou Med. Coll. 24: 452-453.
11. Jia YB, Dong WJ, Cao Y and Yan Y (2009). No Association Between Two SNPs in the IGFBP1 Gene and Esophageal Squamous Cell Carcinoma. J. Baotou Med. Coll. 25: 7-8.
12. Jones JI and Clemmons DR (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16: 3-34.
13. Kaaks R (2004). Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found. Symp. 262: 247-260.
14. Kotsinas A, Evangelou K, Sideridou M, Kotzamanis G, et al. (2008). The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer. Cancer Lett. 259: 177-185.
15. Lettre G, Butler JL, Ardlie KG and Hirschhorn JN (2007). Common genetic variation in eight genes of the GH/IGF1 axis does not contribute to adult height variation. Hum. Genet. 122: 129-139.
16. Li HR, Chen YS, Shao H, Han LL, et al. (2012). Association between polymorphisms of insulin-like growth factor receptor gene and susceptibility to non-small-cell lung cancer in Fujian Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 29: 300-305.
17. Lin IH, Ho ML, Chen HY, Lee HS, et al. (2012). Smoking, green tea consumption, genetic polymorphisms in the insulin-like growth factors and lung cancer risk. PLoS One 7: e30951.
18. MacDonald K, Porter GA, Guernsey DL, Zhao R, et al. (2009). A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma. Cancer Epidemiol. 33: 37-40.
19. McElholm AR, McKnight AJ, Patterson CC, Johnston BT, et al. (2010). A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence. Gastroenterology 139: 204-212.
20. Moon JW, Chang YS, Ahn CW, Yoo KN, et al. (2006). Promoter-202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk. Int. J. Cancer 118: 353-356.
21. Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680.
22. Pollak MN, Schernhammer ES and Hankinson SE (2004). Insulin-like growth factors and neoplasia. Nat. Rev. Cancer 4: 505-518.
23. Pollak M (2008). Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 8: 915-928.
24. Ponder BA (2001). Cancer genetics. Nature 411: 336-341.
25. Rudd MF, Webb EL, Matakidou A, Sellick GS, et al. (2006). Variants in the GH-IGF axis confer susceptibility to lung cancer. Genome Res. 16: 693-701.
26. Serre D, Montpetit A, Pare G, Engert JC, et al. (2008). Correction of population stratification in large multi-ethnic association studies. PLoS One 3: e1382.
27. Stroup DF, Berlin JA, Morton SC, Olkin I, et al. (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
28. Tabor HK, Risch NJ and Myers RM (2002). Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat. Rev. Genet. 3: 391-397.
29. Vogelstein B and Kinzler KW (2004). Cancer genes and the pathways they control. Nat. Med. 10: 789-799.
30. Yi HK, Kim SY, Hwang PH, Kim CY, et al. (2005). Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Biochem. Biophys. Res. Commun. 330: 760-767.
31. Zintzaras E and Ioannidis JP (2005). HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21: 3672-3673.